fda

I was prescribed a common antibiotic for a mild infection and wasn’t told the risks… now I’m disabled and blind

by

The Growing Concern Over Fluoroquinolone Antibiotics A new wave of awareness is sweeping across the United States, shedding light on the potentially severe side effects of fluoroquinolone antibiotics. These powerful medications, including brands like Cipro, have been linked to long-lasting, and sometimes life-altering, adverse reactions. The story of Mateo Rodriguez exemplifies the personal struggles and … Read more

I was prescribed a common antibiotic and wasn’t told of the risks… I’m now disabled and need 24/7 care

by

Understanding the Risks of Fluoroquinolone Antibiotics Fluoroquinolones, a class of antibiotics that includes drugs like ciprofloxacin (Cipro), are powerful medications used to treat a variety of bacterial infections. However, their use has been under scrutiny due to potential severe side effects. The Case of Talia Smith and Others Talia Smith’s story is a harrowing example … Read more

Fall Prevention Strategies Needed for Adults With COPD

by

Fall Risks and COPD: Understanding the Connection New research indicates a significant association between high fall-risk increasing drug (FRID) burden and injurious falls among adults with chronic obstructive pulmonary disease (COPD) near the end of life.1 This study, led by Dr. Cara L. McDermott, reveals the complexities in managing COPD symptoms while minimizing the risk … Read more

GLP-1 RAs Provide Greater Hepatic Benefit Than SGLT2is For MASLD, Type 2 Diabetes

by

The Evolving Landscape of Liver Disease Treatment: GLP-1 Receptor Agonists vs. SGLT2 Inhibitors Recent studies have spotlighted the effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) over sodium-glucose cotransporter-2 inhibitors (SGLT2i) in managing liver conditions associated with type 2 diabetes (T2D). This breakthrough has potential ramifications for the future of liver disease treatment, particularly for … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]